Cargando…
Reply letter to comments on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis
Autores principales: | Xu, Zhihong, Pothula, Srinivasa, Goldstein, David, Pirola, Romano C., Wilson, Jeremy S., Apte, Minoti V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591491/ https://www.ncbi.nlm.nih.gov/pubmed/32719547 http://dx.doi.org/10.1038/s41416-020-1004-6 |
Ejemplares similares
-
Targeting HGF/c-MET Axis in Pancreatic Cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2020) -
Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis
por: Xu, Zhihong, et al.
Publicado: (2020) -
Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2017) -
HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer
por: Pang, Tony C. Y., et al.
Publicado: (2021) -
Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer
por: Pothula, Srinivasa P, et al.
Publicado: (2016)